Inception Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
38-11 Place Du Commerce Suite 195, Verdu...Revenue
<$5 MillionIndustry
About Inception Therapeutics
Inception Therapeutics (ITI) was incorporated in 2013 and is located in Montréal, Canada. ITI is a spin off from University of Montreals Centre Hospitalier Universitaire Sainte-Justines (CHU Sainte-Justine) Research Center. The company recently secured a global license for the development and marketing rights of an early osteoarthritis (OA) diagnostic test and small molecule therapeutics. ITI is focussed at better understanding the Molecular Genetics involved at the inception of diseases to find novel Diagnostics and Therapeutic solutions. The company is targeting chronic and disabling adult and pediatric diseases such as osteoarthritis, muscular dystrophy and other musculoskeletal related diseases. ITIs business model is based on maximizing value creation during the development phases of its diagnostic tests and small molecule therapeutics and to ultimately out-license its therapeutics and companion diagnostic tests to a major pharmaceutical, biotechnology or diagnostic tests companieRead more
SIC Code 87,873NAICS Code 54,541Show moreInception Therapeutics Org Chart
Compare Similar Companies to Inception Therapeutics
Compare insights from companies similar to Inception Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inception Therapeutics Tech Stack
A closer look at the technologies used by Inception Therapeutics
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding Inception Therapeutics
Sign Up For FreeTo access detailed company insights
Inception Therapeutics (ITI) was incorporated in 2013 and is located in Montréal, Canada. ITI is a spin off from University of Montreals Centre Hospitalier Universitaire Sainte-Justines (CHU Sainte-Justine) Research Center. The company recently secured a global license for the development and marketing rights of an early osteoarthritis (OA) diagnos... Read More